The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs.

Source:http://linkedlifedata.com/resource/pubmed/id/11044744

Download in:

View as

General Info

PMID
11044744